0001466049-11-000051.txt : 20110526 0001466049-11-000051.hdr.sgml : 20110526 20110526165138 ACCESSION NUMBER: 0001466049-11-000051 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110524 FILED AS OF DATE: 20110526 DATE AS OF CHANGE: 20110526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Steiner Solomon CENTRAL INDEX KEY: 0001304170 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 11874692 MAIL ADDRESS: STREET 1: C/O VYTERIS, INC. 13-01 POLLITT DRIVE CITY: FAIR LAWN STATE: NJ ZIP: 07410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biodel Inc CENTRAL INDEX KEY: 0001322505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 100 SAW MILL ROAD CITY: DANBURY STATE: CT ZIP: 06810 BUSINESS PHONE: 203-796-5000 MAIL ADDRESS: STREET 1: 100 SAW MILL ROAD CITY: DANBURY STATE: CT ZIP: 06810 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2011-05-24 0001322505 Biodel Inc BIOD 0001304170 Steiner Solomon C/O BIODEL INC. 100 SAW MILL ROAD DANBURY CT 06810 1 0 0 0 Common Stock 2011-05-24 4 S 0 49739 2.06 D 2878758 I See Footnote (2) Common Stock 2011-05-25 4 S 0 91859 2.01 D 2786899 I See Footnote (2) This transaction was executed in multiple trades at prices ranging from $2.03 to $2.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The amount shown represents shares of the Issuer beneficially owned by Steiner Ventures, LLC which shares may be deemed attributable to the Reporting Person because the Reporting Person is the sole managing member of Steiner Ventures, LLC. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein. This transaction was executed in multiple trades at prices ranging from $2.00 to $2.06 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/Paul S. Bavier, Attorney-in-fact 2011-05-26